Literature DB >> 24484779

Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.

M Koëter1, L N van Steenbergen2, V E P P Lemmens3, H J T Rutten4, J A Roukema5, B P L Wijnhoven6, G A P Nieuwenhuijzen7.   

Abstract

BACKGROUND: Surgical treatment of oesophageal cancer in the Netherland is performed in high volume centres. However, the decision to refer patients for curative surgery is made in the referring hospital of diagnosis. The objective of this study was to determine the influence of hospital of diagnosis on the probability of receiving a curative treatment and survival. MATERIAL AND
METHOD: All patients with resectable oesophageal cancer (cT1-3, cN0-3, cM0-1A) diagnosed between 2003 and 2010 (n = 849) were selected from the population-based Eindhoven Cancer Registry, an area with ten non-academic hospitals. Multivariate logistic regression analysis was conducted to examine the independent influence of hospital of diagnosis on the probability to receive curative treatment. Furthermore, the effect of hospital of diagnosis on overall survival was examined using multivariate Cox regression analysis.
RESULTS: 849 patients were included in the study. A difference in proportion of patients referred for surgery was observed ranging from 33% to 67% (p = 0.002) between hospitals of diagnosis. Multivariate logistic regression analysis confirmed the effect of hospital of diagnosis on the chance of undergo curative treatment (OR 0.1, 95% CI 0.1-0.4). Multivariate Cox regression analysis showed that hospital of diagnosis also had an effect on overall survival, up to hazard ratio (HR) 2.2 (95% CI 1.3-3.7).
CONCLUSION: There is a strong relation between hospital of diagnosis and the chance of referring patients with oesophageal cancer for a curative treatment as well as overall survival. Patients diagnosed with oesophageal cancer should be discussed within a regional multidisciplinary expert panel.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Curative surgery; Hospital of diagnosis; Oesophageal cancer; Survival

Mesh:

Year:  2014        PMID: 24484779     DOI: 10.1016/j.ejso.2013.12.024

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

Review 1.  Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

Authors:  Peter S N van Rossum; Nadia Haj Mohammad; Frank P Vleggaar; Richard van Hillegersberg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-12-13       Impact factor: 46.802

2.  Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA.

Authors:  Daniela Molena; Miloslawa Stem; Amanda L Blackford; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2016-08-15       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.